World Health Organization. Medication safety in polypharmacy. World Health Organization. Geneva, Switzerland; 2019.
Varghese D, Ishida C, Koya HH. Polypharmacy. Stat Pearls. 2022. p. 1–9. Available from: https://www.ncbi.nlm.nih.gov/books/NBK532953/. Accessed 29 Oct 2023.
Pazan F, Wehling M. Polypharmacy in older adults: a narrative review of definitions, epidemiology and consequences. Eur Geriatr Med. 2021;12(3):443–52.
PubMed PubMed Central Google Scholar
Mair A, Fernandez-Llimos F, Alonso A, et al. Polypharmacy management by 2030: a patient safety challenge. Edinburgh: SIMPATHY Consortium; 2017.
Hall NJ, Donovan G, Wilkes S. A qualitative synthesis of pharmacist, other health professional and lay perspectives on the role of community pharmacy in facilitating care for people with long-term conditions. Res Social Adm Pharm. 2018;14(11):1043–57.
Mossialos E, Courtin E, Naci H, et al. From “ retailers ” to health care providers : transforming the role of community pharmacists in chronic disease management. Health Policy (New York). 2015;119:628–39.
Ruiz-Ramos J, Juanes-Borrego A, Puig-Campany M, et al. Cost-effectiveness analysis of implementing a secondary prevention programme in those patients who visited an emergency department for drug-related problems. Int J Pharm Pract. 2022;30(5):434–40.
Juanes A, Ruíz J, Puig M, et al. The effect of the drug-related problems prevention bundle on early readmissions in patients from the emergency department: a randomized clinical trial. Ann Pharmacother. 2023;57(9):1025–35.
Social Security Statute Book. § 129 SGB 5—Einzelnorm. Germany; Available from: https://www.gesetze-im-internet.de/sgb_5/__129.html. Accessed 08 Jan 2024.
Pharmaceutical Care Network Europe (PCNE). Position paper on the PCNE definition of medication review. 2016. p. 3. Available from: https://www.pcne.org/upload/files/149_Position_Paper_on_PCNE_Medication_Review_final.pdf. Accessed 08 Jan 2024.
Schulz M, Griese-Mammen N. Müller U. Clinical pharmacy services are reimbursed in Germany: challenges of real world implementation remain. Int J Clin Pharm. 2023;45(1):245–9.
Sucker-Sket K. Ein langer Weg, damit das Richtige in die Tüte kommt. Dtsch Apothekerzeitung. 2023;23:1–15.
Pereira CEO, Bambirra EHF, Fernandes BD, et al. Factors influencing the implementation of pharmaceutical care in outpatient settings : a systematic review applying the Consolidated Framework for Implementation Research. Res Social Adm Pharm. 2022;18(4):2579–92.
Hossain LN, Fernandez-Llimos F, Luckett T, et al. Qualitative meta-synthesis of barriers and facilitators that influence the implementation of community pharmacy services: perspectives of patients, nurses and general medical practitioners. BMJ Open. 2017;7(9):e015471–e015471.
PubMed PubMed Central Google Scholar
Weir NM, Newham R, Dunlop E, et al. Factors influencing national implementation of innovations within community pharmacy: a systematic review applying the Consolidated Framework for Implementation Research. Implement Sci. 2019;14(1):1–16.
Peters DH, Adam T, Alonge O, et al. Implementation research: what it is and how to do it. BMJ. 2013;347(6753):1–7.
Gastelurrutia MÁ, Fernández-Llimos F, Benrimoj SI, et al. Barreras para la implantación de servicios cognitivos en la farmacia comunitaria española. Aten Primaria. 2007;39(9):465–70.
Michel DE, Tonna AP, Dartsch DC, et al. Experiences of key stakeholders with the implementation of medication reviews in community pharmacies: a systematic review using the Consolidated Framework for Implementation Research (CFIR ). Res Social Adm Pharm. 2022;18(6):2944–61.
Waltering I, Schwalbe O, Hempel G. Identification of factors for a successful implementation of medication reviews in community pharmacies: using positive deviance in pharmaceutical care. Int J Clin Pharm. 2022;44(1):79–89.
Smith JD, Li DH, Rafferty MR. The implementation research logic model: a method for planning, executing, reporting, and synthesizing implementation projects. Implement Sci. 2020;15(1):1–12.
Lewis CC, Klasnja P, Powell BJ, et al. From classification to causality: advancing understanding of mechanisms of change in implementation science. Front Public Health. 2018;6(136).
Bauer MS, Kirchner JA. Implementation science: what is it and why should I care? Psychiatry Res. 2020;283(112376).
Blümel M, Spranger A, Achstetter K, et al. Germany: health system review. Health Syst Transit. 2022;22(6):i–273.
Bundesministerium der Justiz. Gesetz über das Apothekenwesen (Apothekengesetz-ApoG). § 2 Available from: https://www.gesetze-im-internet.de/apog/BJNR006970960.html. Accessed 08 Jan 2024.
Federal Union of German Associations of Pharmacists (ABDA). German Pharmacies-Figures-Data-Facts 2023. Available from: https://www.abda.de/en/. Accessed 08 Jan 2024.
GKV Spitzenverband Rahmenvertrag zur Arzneimittelversorgung Available from: https://www.gkv-spitzenverband.de/krankenversicherung/arzneimittel/rahmenvertraege/rahmenvertraege.jsp. Accessed 08 Jan 2024.
Rose O, Richling I, Voigt K, et al. Patient selection and general practitioners’ perception of collaboration in medication review. Res Social Adm Pharm. 2018;15(5):521–7.
Michel DE, Tonna AP, Dartsch DC, et al. Just a ‘ romantic idea ’? A theory - based interview study on medication review implementation with pharmacy owners. Int J Clin Pharm. 2023;45:451–60.
PubMed PubMed Central Google Scholar
Powell BJ, Waltz TJ, Chinman MJ, et al. A refined compilation of implementation strategies: results from the expert recommendations for implementing change (ERIC) project. Implement Sci. 2015;10(1):1–14.
Cantrill JA, Sibbald B, Buetow S. The Delphi and nominal group techniques in health services research. Int J Pharm Pract. 1996;4(2):67–74.
McMillan SS, King M, Tully MP. How to use the nominal group and Delphi techniques. Int J Clin Pharm. 2016;38(3):655–62.
PubMed PubMed Central Google Scholar
Rankin NM, McGregor D, Butow PN, et al. Adapting the nominal group technique for priority setting of evidence-practice gaps in implementation science. BMC Med Res Methodol. 2016;16(1):1–9.
Michel DE, Iqbal A, Faehrmann L, et al. Using an online nominal group technique to determine key implementation factors for COVID-19 vaccination programmes in community pharmacies. Int J Clin Pharm. 2021;43(6):1705–17.
CAS PubMed PubMed Central Google Scholar
Hermansyah A, Pitaloka D, Sainsbury E, et al. Prioritising recommendations to advance community pharmacy practice. Res Social Adm Pharm. 2018;14(12):1147–56.
Newlands RS, Power A, Young L, et al. Quality improvement of community pharmacy services: a prioritisation exercise. Int J Pharm Pract. 2018;26(1):39–48.
Arakawa N, Bader LR. Consensus development methods: considerations for national and global frameworks and policy development. Res Social Adm Pharm. 2021;18(1):2222–9.
Michel DE, Weidmann AE, Dartsch DC. Medikationsanalyse : Nur eine romantische Idee ? Dtsch Apothekerzeitung. 2023;7:2400–1.
Harb SI, Tao L, Peláez S, et al. Methodological options of the nominal group technique for survey item elicitation in health research: a scoping review. J Clin Epidemiol. 2021;139:140–8.
Malterud K, Siersma VD, Guassora AD. Sample size in qualitative interview studies: guided by information power. Qual Health Res. 2016;26(13):1753–60.
McMillan SS, Sav A, Kelly F, et al. Using the nominal group technique: how to analyse across multiple groups. Heal Serv Outcomes Res Methodol. 2014;14(3):92–108.
Drisko JW, Maschi T. Basic content analysis. In: Drisko J, Maschi T, editors. Content analysis. New York: Oxford University Press; 2015.
Rice DB, Cañedo-Ayala M, Turner KA, et al. Use of the nominal group technique to identify stakeholder priorities and inform survey development: an example with informal caregivers of people with scleroderma. BMJ Open. 2018;8(3):1–9.
Van Breda A. Steps to analysing multiple-group NGT data. Soc Work Pract. 2005;17(1):1–14.
Proctor E, Silmere H, Raghavan R, et al. Outcomes for implementation research: conceptual distinctions, measurement challenges, and research agenda. Adm Policy Ment Health. 2011;38(2):65–76.
Livet M, Blanchard C, Richard C, et al. Measuring implementation of medication optimization services: development and validation of an implementation outcomes questionnaire. Res Social Adm Pharm. 2021;17(9):1623–30.
Moullin JC, Sabater-Hernández D, Benrimoj SI. Model for the evaluation of implementation programs and professional pharmacy services. Res Social Adm Pharm. 2016;12(3):515–22.
What is EPIS? — EPIS Framework. Available from: https://episframework.com/what-is-epis. Accessed 23 July 2023.
MacKeigan LD, Ijaz N, Bojarski EA, et al. Implementation of a reimbursed medication review program: corporate and pharmacy level strategies. Res Social Adm Pharm. 2017;13(5):947–58.
Hohmeier KC, Renfro C, Turner K, et al. The Tennessee Medicaid medication therapy management program: early stage contextual factors and implementation outcomes. BMC Health Serv Res. 2021;21(1):1–13.
Ching D, El-Khatib H, Pattin AJ. Strategy to improve efficiency of comprehensive medication reviews in a community pharmacy. J Pharm Technol. 2019;35(5):194–202.
PubMed PubMed Central Google Scholar
Adeoye OA, Lake LM, Lourens SG, et al. What predicts medication therapy management completion rates? The role of community pharmacy staff characteristics and beliefs about medication therapy management. J Am Pharm Assoc. 2018;58(4):S7–15.
Murray ME, Barner JC, Pope ND, et al. Impact and feasibility of implementing a systematic approach for medication therapy management in the community pharmacy setting: a pilot study. J Pharm Pract. 2018;32(6):664–70.
Stafford R, Thomas J, Payakachat N, et al. Using an array of implementation strategies to improve success rates of pharmacist-initiated medication therapy management services in community pharmacies. Res Social Adm Pharm. 2017;13(5):938–46.
Varas-Doval R, Gastelurrutia MA, Benrimoj SI, et al. Evaluating an implementation programme for medication review with follow-up in community pharmacy using a hybrid effectiveness study design: translating evidence into practice. BMJ Open. 2020;10(9).
Garcia-Cardenas V, Benrimoj ShI, Castrillon Ocampo C, et al. Evaluation of the implementation process and outcomes of a professional pharmacy service in a community pharmacy setting: A case report. Res Social Adm Pharm. 2017;13(3):614–27.
Bradley F, Wagner AC, Elvey R, et al. Determinants of the uptake of medicines use reviews (MURs) by community pharmacies in England: a multi-method study. Health Policy (New York). 2008;88(2/3):258–68.
Blenkinsopp A, Celino G, Bond C, et al. Medicines use reviews: the first year of a new community pharmacy service. Pharm J. 2007;278(7440):218–23.
Fairchild RJ, Lischetzki J. The conflict of interest inherent to community pharmacy in England: a game-theoretic analysis of the failure of the medicines use review (MUR) service. SSRN Electron J. 2021;(9):0–68.
Community Pharmacy England. MUR statistics—archive information. 2022. https://cpe.org.uk/funding-and-reimbursement/nhs-statistics/mur-statistics/. Accessed 08 Jan 2024.
Curran GM, Bauer M, Mittman B, et al. Effectiveness-implementation hybrid designs: combining elements of clinical effectiveness and implementation research to enhance public health impact. Med Care. 2013;50(3):217–26.
Comments (0)